Estramustine phosphate in the treatment of hormone escape prostatic carcinoma - a 3 year follow-up

Objective: A recent literature review has shown rekin-dled interest in the use of estramustine phosphate (EMP) inpatients with advanced prostatic cancer. This led us to assess prostate specific antigen (PSA ) response and drug tolerability following EMP therapy inpatients with hor-mone refractory p...

Full description

Bibliographic Details
Main Authors:	Altaf H Syed, Mohd N Akhtar, C Shearing, P R Bollina, D N Tulloch
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2003-01-01
Series:	Indian Journal of Urology
Subjects:	Estramustine phosphate. prostate specific antigen. advanced prostate cancer bone pain side effects/toxicity.
Online Access:	http://www.indianjurol.com/article.asp?issn=0970-1591;year=2003;volume=19;issue=2;spage=129;epage=134;aulast=Syed

Internet

http://www.indianjurol.com/article.asp?issn=0970-1591;year=2003;volume=19;issue=2;spage=129;epage=134;aulast=Syed

Estramustine phosphate in the treatment of hormone escape prostatic carcinoma - a 3 year follow-up

Internet

Similar Items